TL;DR:
Phosphatidylcholine (PC) is a nutrient that supports cell membranes and helps repair the gut lining. Research shows it can improve symptoms in ulcerative colitis and protect the stomach from damage caused by NSAIDs like ibuprofen.
What Is Phosphatidylcholine?
Phosphatidylcholine (PC) is a major building block of cell membranes. It helps with cellular repair, making it especially important for tissues that are under constant stress — like the lining of the intestines.
Phosphatidylcholine and Ulcerative Colitis
Ulcerative colitis (UC) is an inflammatory bowel disease marked by chronic damage to the intestinal lining. Several studies have shown that PC supplements can help repair the gut lining and improve UC symptoms.
- In one double-blind, placebo-controlled study of 60 UC patients, 90% improved with PC, and over half went into remission.
- Meta-analyses confirm that delayed-release PC formulas are effective for UC, even in patients who don’t respond to standard treatments.
Protecting the Gut from NSAIDs
Non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen and aspirin can damage the stomach and intestines over time. Research shows that pairing these drugs with PC makes them much safer.
- A study comparing ibuprofen vs. ibuprofen-PC in arthritis patients found that the PC version caused less GI damage while keeping the same pain-relieving effects.
- Another trial showed that aspirin-PC caused fewer ulcers than aspirin alone.
This means PC may be a smart option for people who have been taking NSAIDs or who continue to take them.
Key Takeaways
- PC repairs cells and supports intestinal health.
- Clinical trials show PC helps ulcerative colitis patients, even those resistant to other treatments.
- PC protects against NSAID damage, making common pain relievers safer.
Research on Phosphatidylcholine
- Ann Intern Med. 2007 Nov 6;147(9):603-10 Phosphatidylcholine for steroid-refractory chronic ulcerative colitis: a randomized trial
- Gut. 2005 Jul;54(7):966-71. Retarded release phosphatidylcholine benefits patients with chronic active ulcerative colitis
- Dig Dis. 2021 Jan 13 Delayed Release Phosphatidylcholine is Effective for Treatment of Ulcerative Colitis: A Meta-Analysis
- Am J Gastroenterol. 2014 Jul;109(7):1041-51 First multicenter study of modified release phosphatidylcholine “LT-02” in ulcerative colitis: a randomized, placebo-controlled trial in mesalazine-refractory courses
- Am J Gastroenterol. 2011 Feb;106(2):272-7. Low-dose aspirin-induced ulceration is attenuated by aspirin-phosphatidylcholine: a randomized clinical trial
- Aliment Pharmacol Ther. 2008 Aug 15;28(4):431-42. Clinical trial: comparison of ibuprofen-phosphatidylcholine and ibuprofen on the gastrointestinal safety and analgesic efficacy in osteoarthritic patients
Not Medical Advice
This information is for educational purposes only and not a substitute for professional medical care. Always consult your healthcare provider before making changes to your treatment or supplements.